Michael P. Stansky

Insider Reports History

Location
Boston, MA
Signature
/s/ Mary Szela, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael P. Stansky:

Company Role Class Num Shares Value Price $ Report Date Ownership
TriSalus Life Sciences, Inc. Director Common Stock 787,132 $3,227,241 $4.10 23 Feb 2026 Direct
TriSalus Life Sciences, Inc. Director Common Stock 199,698 $818,761 $4.10 23 Feb 2026 By LLC
TriSalus Life Sciences, Inc. Director Director Stock Option (right to buy) 92,537 04 Feb 2026 Direct

Insider Reports Filed by Michael P. Stansky

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TLSI TriSalus Life Sciences, Inc. 23 Feb 2026 2 +$1,480,502 4 Director 23 Feb 2026, 16:08
TLSI TriSalus Life Sciences, Inc. 04 Feb 2026 1 $0 4 Director 11 Feb 2026, 18:51
TLSI TriSalus Life Sciences, Inc. 04 Feb 2026 0 $0 3 Director 11 Feb 2026, 18:50